CClinicalTrials.gg
Active, not recruitingNCT07299370FNFsUpdated Dec 23, 2025

Open vs Closed Reduction in Femoral Neck Fractures Using Anterolateral vs Direct Lateral Approach

An interventional study of Closed reduction of femoral neck fractures and Open reduction of femoral neck fractures in Femoral Neck Fractures, sponsored by Samer youssef mansour meglaa. Active, not recruiting at 1 site in Egypt. Open to participants aged 16 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-23.

Sponsored by Samer youssef mansour meglaa · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Apr 2026, 5 months ago, but the record still lists the study as active, not recruiting.
  • Registered 7 months after the study started (first participant enrolled Feb 2025, registered Sep 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
3
Allocation
Randomized
Ages
16 Years to 60 Years
Sex
All
01

Study summary

Outcomes of open vs closed reduction if emoral neck fractures

Read the detailed description

Outcomes of open vs closed reduction in femoral neck fractures using anterolateral vs direct lateral approach using dynamic hip screws

02

Conditions studied

  • Femoral Neck Fractures

Keywords

  • Watson jones approach
03

In context

Femoral Neck Fractures

204 studies on the registry are indexed under Femoral Neck Fractures; 41 are open to participants now.

This study's enrollment of 3 is below the median of 100 across 140 interventional studies indexed under Femoral Neck Fractures.

Browse Femoral Neck Fractures studies →

Lead sponsor

Samer youssef mansour meglaa is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
16 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Inclusion criteria:
  • patients of both genders between the ages of 16 to 60 years old and had trauma caused femoral neck fracture.
  • patients of both genders with Garden's type three and four femoral neck fractures

Exclusion Criteria:

  • patients of both genders below the age of 16 and above 60 years old.
  • patients with pathological femoral neck fractures.
  • patients with autoimmune diseases like rheumatoid arthritis.
  • patients with neglected femoral neck fractures(more than 1 week).
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
3 participants (actual)

Study arms

  • Experimental
    Open eduction of femoral neck fractures

    Open reduction Using watson jones approach

    Device: Open reduction of femoral neck fractures

  • Experimental
    Closed reduction of femoral neck fractures

    Using direct lateral approach

    Procedure: Closed reduction of femoral neck fractures

Interventions

  • ProcedureClosed reduction of femoral neck fractures

    Closed reduction of femoral neck fractures

  • DeviceOpen reduction of femoral neck fractures

    Open reduction of femoral neck fractuctures

06

What researchers measure

Primary outcomes

  1. Radiographic evaluation of reduction quality postoperatively

    By measuring : * 1- femoral offset * 2-Neck-length discrepancy * 3 - ante-version angle * 4-step-off

    Time frame: 6 month

Secondary outcomes

  1. Asses patients clinically post operative

    Using Harris Hip Score

    Time frame: 1 year

07

Study locations

1 site
  • Assuit university
    Asyut, Egypt, Egypt
08

References and documents

Publications

  • Ghayoumi P, Kandemir U, Morshed S. Evidence based update: open versus closed reduction. Injury. 2015 Mar;46(3):467-73. doi: 10.1016/j.injury.2014.10.011. Epub 2014 Oct 14. PubMed 25554424 ↗

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07299370
Lead sponsor
Samer youssef mansour meglaa
Responsible party
Samer youssef mansour meglaa (Assistant lecturer, Assiut University) — Sponsor-investigator
First posted
Dec 23, 2025
Start date
Feb 2, 2025
Primary completion
Apr 10, 2026 (estimated)
Completion
Oct 10, 2027 (estimated)
Last update
Dec 23, 2025

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion